Imagine you are reviewing a mid-cap manufacturing firm seeking a fresh credit line from a consortium of Indian banks. The balance sheet shows substantial factory land in an industrial corridor, which the management...
Imagine you are building a valuation model for a major state-owned oil exploration company. You notice that the government, as the majority promoter, is offloading a portion of its equity stake to meet its fiscal deficit...
Imagine you are reviewing the annual report of a mid-cap manufacturing firm that has seen its stock price languish in the single digits for several years. To improve the optics of the stock and perhaps meet internal...
Imagine you are drafting a debt-market outlook for your firm’s monthly research newsletter. The Reserve Bank of India (RBI) has just hinted at a possible repo rate hike, and your clients are worried about their corporate...
Imagine you are finalizing a DCF model for a prominent pharmaceutical company in India. The earnings growth looks consistent, and the cash flows seem robust, but your review of the 'Notes to Accounts' reveals a lingering...
Imagine you are drafting an initiating coverage report on a major Indian integrated steel manufacturer. As you build your discounted cash flow (DCF) model, you notice that the company’s current earnings are at a...
Imagine you are analyzing a mid-sized Indian FMCG firm preparing for a strategic divestiture. The balance sheet shows substantial property, plant, and equipment, but as you dig deeper into the notes, you find a...
You are sitting at your desk reviewing the annual report of a well-established Indian FMCG giant. The company has dominated its category for decades, reporting stable revenue growth of 6% annually, perfectly mirroring...
Imagine you are analyzing a Grade-A commercial office portfolio listed as a Real Estate Investment Trust (REIT) on the NSE. While your initial instinct might be to estimate value based on the underlying property price or...
You are deep into your quarterly review of a leading Indian pharmaceutical company, comparing its growth potential against a domestic software major. You notice the pharma firm records substantial R&D expenditure as...